Skip to content
Clinical Trial Events
SCOPE Summit 2027

Talk Feasibility & Site Strategy track

Beyond Compliance: How TAK-113 Is Outperforming Expectations through Intentional Inclusion

Tue, Mar 2, 2027 · 3:05–3:30 PM EST Rosen Shingle Creek

About this session

Strategic site selection, continuous site feedback, and tailored patient support accelerated enrollment in a clinical trial focused on Black/Latino participants. By prioritizing sites with strong community connections and incorporating operational insights, enrollment barriers were rapidly identified and addressed. Patient-centered resources improved access and participation, resulting in enrollment that outperformed expectations. This success demonstrated the value of intentional inclusion, positioning equity as a recruitment strategy and advancing more representative clinical research.

Speaker

  • Lam Calderon

    Lead Clinical Study Manager · Takeda

    Speaker